The antipsychotic drug Rexulti is new on the market, but researchers are already worried about the medication’s ability to cause impulse-control disorders.

  • Excessive gambling
  • Compulsive shopping

Our attorneys have opened a full investigation into these potential side effects. We need your help. If you or a loved one developed uncontrollable urges after taking Rexulti, contact our experienced lawyers for a free consultation.

Free Rexulti Drug Lawsuit Evaluation

(877) 671-6480

Drug companies have a sworn obligation to warn patients and doctors of their products’ risks.

— Laurence Banville, Esq.
"Excellent Help" Laurence and his staff were extremely responsive.
The Product Lawyers Reviewed by Janice G. on .
Rating: 5.0 ★★★★★

Our experienced product liability attorneys are investigating the potential effect Rexulti, an atypical antipsychotic drug, may have on compulsive behavior. Some medical experts have begun to worry that, like its predecessor medication Abilify, Rexulti may increase the risk for compulsive gambling and shopping.

Abilify’s warning label bears a prominent cautionary note about these risks; the label for Rexulti does not.

If you or a loved one experienced compulsions and uncontrollable urges after taking Rexulti, our lawyers want to here from you. Contact our team today for a free legal consultation to learn more about your rights and options.

What Is Rexulti?

The active ingredient in Rexulti is called brexpiprazole. This atypical (second generation) antipsychotic drug works by partially blocking brain receptors that respond to dopamine and serotonin, two mood-regulating neurotransmitters.

Doctor With Antipsychotic Drug

Free Rexulti Case Evaluation

Free Rexulti Lawsuit Consultations

(877) 671-6480

Approved for the treatment of schizophrenia in the United States in 2015, Rexulti is the only antipsychotic drug based on brexpiprazole available on the market today. It is also approved as an add-on treatment for adults with major depressive disorder.

The Link Between Abilify, Rexulti & Compulsive Behavior

Rexulti was developed through a joint venture between Otsuka Pharmaceuticals and Danish pharmaceutical manufacturer Lundbeck. Rexulti is seen as a successor to Otsuka’s wildly-popular atypical antipsychotic Abilify, the patent for which expired in 2014. And, while Abilify and Rexulti are not identical, both drugs have been linked to some of the same serious side effects.

Researchers have understood for years that Abilify could increase the risk for troubling compulsive behaviors. Patients who take the drug’s active ingredient, aripiprazole, may live at an increased risk of developing compulsive and uncontrollable urges.

Does Otsuka’s New Drug Pose Same Risks?

Now, scientists have raised similar concerns about Rexulti, in part because brexpriprazole and aripiprazole (as their names suggest) are very similar chemicals. In fact, some critics have accused Otsuka of “ever-greening” Abilify – changing the drug’s chemical composition in minor ways that have little effect on the medication’s benefits to maintain intellectual property rights in the market.

Gambling, Shopping Addiction NOT Listed Side Effects

Rexulti gained FDA approval only three months before the first generic version of Abilify reached pharmacy shelves. But the similarity between Rexulti and Abilify has some medical researchers concerned. Abilify now bears strong warnings for patients and medical providers.

Free Rexulti Lawsuit Consultations


Impulse-Control Disorders Devastate Patients, Families

After patients began to step forward with terrifying stories of uncontrollable gambling and shopping, the FDA took action, forcing Otsuka to place prominent warnings about the previously-undisclosed side effects on every package of Abilify. At the same time, hundreds of patients have filed lawsuits against Otsuka, seeking compensation for the severe and devastating effects of gambling, sex, food and shopping addictions.

Many plaintiffs say they’ve lost their loved ones and all of their financial resources to these crippling urges, accusing Otsuka of failing to warn the public and the medical community of the risks.

As we’ve seen, compulsive gambling only made an appearance on Abilify’s warning label after the US Food & Drug Administration stepped in. The same warnings have not been issued for Rexulti, even though both drugs share a similar mechanism of action.

Does Antipsychotic’s Warning Label Go Far Enough?

Instead, Rexulti’s warning label only advises patients who have a history of impulse-control problems to take caution; it does not, anywhere, suggest that a gambling or shopping addiction could be among the drug’s side effects.

“Post-marketing reports of impulse-control disorders,” the label reads, “including pathological gambling and hypersexuality have been reported in patients treated with another antipsychotic with partial agonist activity at dopamine receptors. Patients with a prior history of impulse-control disorder may be at increased risk and should be monitored carefully.”

That other antipsychotic linked to impulse-control disorders? It’s Abilify, Otsuka’s first blockbuster schizophrenia drug. Note, however, how much work the warning label’s language does to distance Rexulti from its predecessor drug. But if Rexulti is really just an “evergreened” version of Abilify, there’s a fair chance that both drugs could share a similar risk profile.

Learn More In A Free Consultation

Did you or a loved one develop a gambling or shopping addiction after being prescribed Rexulti? We can help. Our experienced product liability lawyers have been standing up to big pharmaceutical companies for decades.

Some Rexulti patients may be eligible to file a personal injury lawsuit against Otsuka Pharmaceuticals. In a lawsuit, patients and their loved ones can pursue financial compensation and accountability against a drug company that fails to warn the public of health risks. Patients may be able to recover compensation to make up for their gambling and excessive shopping losses, therapy expenses and emotional trauma.

Learn more about your legal rights in a free consultation today. Just call our attorneys or fill out an online contact form now.

Free Rexulti Lawsuit Consultations


Contact The Product Lawyers for a free consultation

(877) 671-6480

Free Rexulti Case Evaluation

Contact The Product Lawyers for a free consultation

(877) 671-6480